Zhaoyi Wang Selected Research

Zhaoyi Wang Research Topics

Disease

21	Neoplasms (Cancer) 09/2021 - 06/2006
10	Breast Neoplasms (Breast Cancer) 03/2018 - 01/2005
8	Stomach Neoplasms (Stomach Cancer) 01/2020 - 07/2010
6	Carcinogenesis 06/2018 - 01/2005
6	Lymphatic Metastasis 06/2018 - 11/2008
4	Carcinoma (Carcinomatosis) 06/2018 - 02/2011
3	Inflammation (Inflammations) 01/2022 - 01/2020
2	Fibrosis (Cirrhosis) 01/2022 - 01/2022
2	Myocardial Infarction 01/2022 - 01/2020
2	Wounds and Injuries (Trauma) 01/2020 - 01/2019
2	Hypersensitivity (Allergy) 01/2018 - 12/2014
2	Triple Negative Breast Neoplasms 10/2016 - 06/2014
2	Hepatocellular Carcinoma (Hepatoma) 10/2015 - 01/2014
1	Necrosis 01/2022
1	Colonic Neoplasms (Colon Cancer) 01/2022
1	Pathologic Processes 01/2022
1	Ventricular Remodeling 01/2022
1	Atherosclerosis 01/2020
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2019
1	Osteoarthritis 01/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2019
1	Non-alcoholic Fatty Liver Disease 08/2018
1	Neoplasm Metastasis (Metastasis) 03/2018
1	Lung Neoplasms (Lung Cancer) 07/2016
1	Asthma (Bronchial Asthma) 11/2011
1	Respiratory Hypersensitivity 11/2011
1	Wilms Tumor (Wilm's Tumor) 04/2009
1	Colorectal Neoplasms (Colorectal Cancer) 11/2008
1	Tetraploidy 12/2006
1	Glioblastoma (Glioblastoma Multiforme) 12/2006
1	Aneuploidy (Aneuploid) 12/2006

Drug/Important Bio-Agent (IBA)

11	Estrogens (Estrogen)FDA Link 01/2020 - 11/2005
8	Estrogen ReceptorsIBA 01/2020 - 11/2005
7	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2009
6	Estrogen Receptor alphaIBA 07/2010 - 01/2005
5	Tamoxifen FDA LinkGeneric 03/2018 - 07/2009
3	Caveolin 1IBA 02/2011 - 01/2005
3	human estrogen receptor alpha 36IBA 07/2010 - 11/2008
2	Biological ProductsIBA 01/2022 - 01/2014
2	LipidsIBA 01/2022 - 08/2018
2	Biocompatible Materials (Biomaterials)IBA 01/2020 - 01/2019
2	Endoplasmic Reticulum Chaperone BiPIBA 06/2018 - 12/2017
2	Formaldehyde (Formol)FDA Link 12/2014 - 01/2011
2	Cyclin D1IBA 12/2014 - 08/2013
2	ParaffinIBA 12/2014 - 01/2011
2	Transcription Factors (Transcription Factor)IBA 02/2011 - 04/2009
2	Messenger RNA (mRNA)IBA 07/2010 - 11/2008
1	Aspartic Acid (Aspartate)FDA Link 01/2022
1	Elastomers (Elastomer)IBA 01/2022
1	Polyglactin 910IBA 01/2021
1	HydrogelsIBA 01/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020
1	Cadherins (E-Cadherin)IBA 01/2020
1	Long Noncoding RNAIBA 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 06/2018
1	Aldehyde DehydrogenaseIBA 03/2018
1	Hormones (Hormone)IBA 03/2018
1	Antiviral Agents (Antivirals)IBA 01/2018
1	forsythiasideIBA 01/2018
1	AntioxidantsIBA 01/2018
1	RNA (Ribonucleic Acid)IBA 01/2017
1	Anthocyanins (Anthocyanin)IBA 10/2016
1	Antineoplastic Agents (Antineoplastics)IBA 07/2016
1	SNG1153IBA 07/2016
1	Epithelial Cell Adhesion MoleculeIBA 10/2015
1	icaritinIBA 10/2015
1	Progesterone Receptors (Progesterone Receptor)IBA 06/2014
1	human ERBB2 proteinIBA 06/2014
1	anthrapyrazoleIBA 01/2014
1	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2014
1	PolyaminesIBA 01/2014
1	pterostilbeneIBA 01/2014
1	CaspasesIBA 01/2014
1	Pharmaceutical PreparationsIBA 01/2014
1	glucose-regulated proteinsIBA 09/2013
1	AllergensIBA 11/2011
1	MicroRNAs (MicroRNA)IBA 01/2011
1	SynucleinsIBA 08/2010
1	Membrane Proteins (Integral Membrane Proteins)IBA 05/2010
1	CytokinesIBA 12/2006
1	pleiotrophin (HARP)IBA 12/2006
1	Estrogen Receptor Modulators (Antiestrogen)IBA 06/2006

Therapy/Procedure

4	Therapeutics 01/2019 - 06/2006
3	Drug Therapy (Chemotherapy) 09/2021 - 07/2009
1	Radiotherapy 09/2021
1	Neoadjuvant Therapy 06/2014